Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis | Zendy

Susan E. Dorman | Zendy; Payam Nahid | Zendy; Ekaterina V. Kurbatova | Zendy; Patrick Phillips | Zendy; Kia Bryant | Zendy; Kelly E. Dooley | Zendy; Melissa Engle | Zendy; Stefan Goldberg | Zendy; Ha Phan | Zendy; James Hakim | Zendy; John L. Johnson | Zendy; Madeleine Lourens | Zendy; Neil Martinson | Zendy; Grace Muzanyi | Zendy; Kim Narunsky | Zendy; Sandy Nerette | Zendy; Nhung Viet Nguyen | Zendy; Thuong Pham | Zendy; Samuel Pierre | Zendy; Anne Purfield | Zendy; Wadzanai Samaneka | Zendy; Radojka M. Savić | Zendy; Ian Sanne | Zendy; Nigel Scott | Zendy; Justin Shenje | Zendy; Erin Sizemore | Zendy; Andrew Ver | Zendy; Ziyaad Waja | Zendy; Marc Weiner | Zendy; Susan Swindells | Zendy; Richard E. Chaisson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis

Author(s) -

Susan E. Dorman,

Payam Nahid,

Ekaterina V. Kurbatova,

Patrick Phillips,

Kia Bryant,

Kelly E. Dooley,

Melissa Engle,

Stefan Goldberg,

Ha Phan,

James Hakim,

John L. Johnson,

Madeleine Lourens,

Neil Martinson,

Grace Muzanyi,

Kim Narunsky,

Sandy Nerette,

Nhung Viet Nguyen,

Thuong Pham,

Samuel Pierre,

Anne Purfield,

Wadzanai Samaneka,

Radojka M. Savić,

Ian Sanne,

Nigel Scott,

Justin Shenje,

Erin Sizemore,

Andrew Ver,

Ziyaad Waja,

Marc Weiner,

Susan Swindells,

Richard E. Chaisson

Publication year - 2021

Publication title -

new england journal of medicine

Language(s) - English

Resource type - Journals

eISSN - 1533-4406

pISSN - 0028-4793

DOI - 10.1056/nejmoa2033400

Subject(s) - rifapentine , moxifloxacin , tuberculosis , antimycobacterial , medicine , pulmonary tuberculosis , rifamycin , antibiotics , pharmacology , mycobacterium tuberculosis , latent tuberculosis , microbiology and biotechnology , biology , pathology

Rifapentine-based regimens have potent antimycobacterial activity that may allow for a shorter course in patients with drug-susceptible pulmonary tuberculosis.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research